MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer

Human Immunology

Volumn 70, Issue 6, 2009, Pages 436-439

  Segat, Ludovica ^a   Crovella, Sergio ^a   Comar, Manola ^b   Milanese, Michele ^a   Zanotta, Nunzia ^b   Fabris, Annalisa ^a   Trevisiol, Chiara ^c   Rossi, Tatiana ^a   De Seta, Francesco ^b   Campello, Cesare ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c Pediatric Unit San Polo Hospital   (Italy)

Author keywords

Cervical cancer; Genetic polymorphisms; High risk HPV; Innate immunity; MBL2

Indexed keywords

DNA; MANNOSE BINDING LECTIN 2;

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION RISK; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VIRUS STRAIN;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MANNOSE-BINDING LECTIN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 67349139917     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.03.006     Document Type: Article

References (20)

1. Kim Y.T., and Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J 46 (2005) 597-618
2. Turner M.W. The role of mannose-binding lectin in health and disease. Mol Immunol 40 (2003) 423-429
3. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.L., and Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167 (2001) 2861-2868
4. Bierl C., Karem K., Poon A.C., Swan D., Tortolero-Luna G., Follen M., et al. Correlates of cervical mucosal antibodies to human papillomavirus 16: Results from a case control study. Gynecol Oncol 99 (2005) S262-S268
5. Nguyen H.H., Broker T.R., Chow L.T., Alvarez R.D., Vu H.L., Andrasi J., et al. Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol 96 (2005) 452-461
6. Gonçalves A.K., Giraldo P., Barros-Mazon S., Gondo M.L., Amaral R.L., and Jacyntho C. Secretory immunoglobulin A in saliva of women with oral and genital HPV infection. Eur J Obstet Gynecol Reprod Biol 124 (2006) 227-231
7. Madsen H.O., Garred P., Thiel S., Kurthalzs J.A., Laam L.U., Ryder L.P., et al. Interplay between promotor and structural gene variants control basal serum level of mannan-binding protein. J Inmunol 155 (1995) 3013-3020
8. Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W., et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 337 (1991) 1569-1570
9. Madsen H.O., Garred P., Kurtzhals J.A., Lamm L.U., Ryder L.P., Thiel S., et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40 (1994) 37-44
10. Wallis R., and Cheng J.Y. Molecular defects in variant forms of mannose-binding protein associated with immunodeficiency. J Immunol 163 (1999) 4953-4959
11. Garred P., Madsen H.O., Balslev U., Hofmann B., Pedersen C., Gerstoft J., et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349 (1997) 236-240
12. Milanese M., Segat L., De Seta F., Pirulli D., Fabris A., Morgutti M., et al. MBL2 genetic screening in patients with recurrent vaginal infections. Am J Reprod Immunol 59 (2008) 146-151
13. Madsen H.O., Satz M.L., Hogh B., Svejgaard A., and Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 161 (1998) 3169-3175
14. Bernig T., Breunis W., Brouwer N., Hutchinson A., Welch R., Roos D., et al. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannose-binding lectin. Hum Genet 118 (2005) 404-415
15. Skalnikova H., Freiberger T., Chumchalova J., Grombirikova H., and Sediva A. Cost-effective genotyping of human MBL2 gene mutations using multiplex PCR. J Immunol Methods 295 (2004) 139-147
16. Steffensen R., Thiel S., Varming K., Jersild C., and Jensenius J.C. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 241 (2000) 33-42
17. Casanova J.L., and Abel L. Human mannose-binding lectin in immunity: Friend, foe, or both?. J Exp Med 199 (2004) 1295-1299
18. Parrella P., Seripa D., Matera M.G., Rinaldi M., Signori E., Gravina C., et al. Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection. Eur J Epidemiol 22 (2007) 159-162
19. Guimaraes V., Guimaraes R., Brandao L., Baldez da Silva M.F., Milanese M., Segat L., et al. Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women. Hum Immunol 69 (2008) 273-278
20. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.L., and Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167 (2001) 2861-2868